RCT of Combination Effect of Vibration Treatment and HMB Supplementation on Myosteatosis and NMJ Degeneration

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60+
SponsorChinese University of Hong Kong

About this trial

The investigators' pre-clinical study confirms the positive effects of combined treatment (VT + HMB) on reducing fat-to-lean tissue ratio, intramuscular fat infiltration and increasing muscle strength in sarcopenia animal model. The results showed that fat mass could be decreased by \~32%, while histology Oil Red O staining indicated a decrease of fat by almost 60%; in contrast, lean muscle mass increased by \~14%. On muscle strength, combined treatment increased twitch force, tetanic force and grip strength by \~30-66%. These in vivo results are very encouraging and the investigators should explore its potential in clinical translation. As VT and HMB supplement have been commercially available and their compliance rates are satisfactory, they can be translated to clinical application easily. The investigators' next step is to confirm its clinical efficacy, so that sarcopenia becomes a new indication of VT and HMB. The hypothesis is that combined treatment of VT and HMB can retard the progression of sarcopenia in human, in terms of muscle mass, muscle strength and performance.

Eligibility criteria

Qualifiers

Subjects aged 60 years or above

Subjects failed in AWGS algorithm

skeletal muscle mass by BIA (male at <7.0 kg/m², female at <5.7 kg/m²), and

handgrip strength (male at <28 kg, female at <18kg), and/or

Disqualifiers

Subjects with pathological bone diseases

Subjects with chronic inflammatory condition (e.g. rheumatoid arthritis)

Subjects with neurological problems

Subjects receiving regular exercise

Trial design

Treatments tested in this trial

  • Low-magnitude High-frequency Vibration
  • β-hydroxy β-methylbutyrate (HMB) supplement
  • Protein supplement

Treatment groups

200 Participants
are divided into 4 treatment groups

Sponsors and collaborators